Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter J Lukiw

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Expert Opinion on Emerging Drugs|March 24, 2012
Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD)Walter J Lukiw
Expert Opinion on Emerging Drugs|June 10, 2008
Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD)Walter J Lukiw
Neuroreport|February 23, 2007
Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampusWalter J Lukiw
Biomolecules|February 25, 2022
Recent Advances in Our Molecular and Mechanistic Understanding of Misfolded Cellular Proteins in Alzheimer's Disease (AD) and Prion Disease (PrD)Walter J Lukiw
Frontiers in Cell and Developmental Biology|June 5, 2023
Commentary: A tribute to Dr. Paul Berg (1926-2023) American biochemist, Nobel Laureate and discoverer of recombinant DNA technology, vaccine and genetic engineeringWalter J Lukiw
Frontiers in Genetics|January 16, 2014
Circular RNA (circRNA) in Alzheimer's disease (AD)Walter J Lukiw
Expert Review of Neurotherapeutics|June 1, 2006
Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's diseaseWalter J Lukiw
Frontiers in Neuroscience|January 24, 2022
New Inroads Into Our Understanding of the Tauopathies, Alzheimer's Disease, and the Contribution of Altered Protein Conformation to Human Neurological DiseaseWalter J Lukiw
Frontiers in Neurology|July 17, 2020
microRNA-146a Signaling in Alzheimer's Disease (AD) and Prion Disease (PrD)Walter J Lukiw
Journal of Alzheimer'S Disease & Parkinsonism|September 3, 2021
SARS-CoV-2, the Angiotensin Converting Enzyme 2 (ACE2) Receptor and Alzheimer's diseaseWalter J Lukiw
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Expert Opinion on Emerging Drugs|March 24, 2012
Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD)Walter J Lukiw
Expert Opinion on Emerging Drugs|June 10, 2008
Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD)Walter J Lukiw
Neuroreport|February 23, 2007
Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampusWalter J Lukiw
Biomolecules|February 25, 2022
Recent Advances in Our Molecular and Mechanistic Understanding of Misfolded Cellular Proteins in Alzheimer's Disease (AD) and Prion Disease (PrD)Walter J Lukiw
Frontiers in Cell and Developmental Biology|June 5, 2023
Commentary: A tribute to Dr. Paul Berg (1926-2023) American biochemist, Nobel Laureate and discoverer of recombinant DNA technology, vaccine and genetic engineeringWalter J Lukiw
Frontiers in Genetics|January 16, 2014
Circular RNA (circRNA) in Alzheimer's disease (AD)Walter J Lukiw
Expert Review of Neurotherapeutics|June 1, 2006
Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's diseaseWalter J Lukiw
Frontiers in Neuroscience|January 24, 2022
New Inroads Into Our Understanding of the Tauopathies, Alzheimer's Disease, and the Contribution of Altered Protein Conformation to Human Neurological DiseaseWalter J Lukiw
Frontiers in Neurology|July 17, 2020
microRNA-146a Signaling in Alzheimer's Disease (AD) and Prion Disease (PrD)Walter J Lukiw
Journal of Alzheimer'S Disease & Parkinsonism|September 3, 2021
SARS-CoV-2, the Angiotensin Converting Enzyme 2 (ACE2) Receptor and Alzheimer's diseaseWalter J Lukiw
Pageof 20